Latest News and Press Releases
Want to stay updated on the latest news?
-
Elraglusib oral tablet formulation to drive next-phase clinical development and broader clinical useFDA cleared IND for Phase 1/2 study of oral elraglusib in advanced cancer patients, with focus on...
-
SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for...
-
1Q 2026 Earnings
-
Q1 gold production of 719,000 ounces1 beats guidance of 640,000–680,000 ounces1, driven by strong performances at NGM and Veladero, and the ramp-up at Loulo-Gounkoto; copper production of 49,000...
-
Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Van Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ResearchAndMarkets.com's offering. The...
-
Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Generative AI Server Market by Processor Type, Function, Form Factor, Deployment, Cooling Technology, End User - Global Forecast to 2030" has been added...
-
MELBOURNE, Australia, May 11, 2026 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of symptomatic...
-
VANCOUVER, Canada, May 11, 2026 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTCQB: ORRCF) ("Oroco" or the "Company") is pleased to announce the appointment of Charles Cryer as Chief...
-
Tallmadge, OH, May 10, 2026 (GLOBE NEWSWIRE) -- As consumer demand for metabolism-focused wellness products continues to rise in 2026, Jelly Tide has rapidly gained attention across the dietary...
-
MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where MoonLake and the FDA aligned on submission plans and the...